デフォルト表紙
市場調査レポート
商品コード
1367906

世界の薬力学的(PD)バイオマーカー市場

Global Pharmacodynamic (PD) Biomarkers Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

出版日: | 発行: QYResearch | ページ情報: 英文 87 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.56円
世界の薬力学的(PD)バイオマーカー市場
出版日: 2023年10月25日
発行: QYResearch
ページ情報: 英文 87 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、薬力学的(PD)バイオマーカー (Pharmacodynamic (PD) Biomarkers) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 市場概要 : 薬力学的(PD)バイオマーカー

  • 薬力学的(PD)バイオマーカー 市場の事業概要
    • 薬力学的(PD)バイオマーカー 製品範囲
    • Pharmacodynamic (PD) Biomarkers Market Status and Outlook
  • 世界の薬力学的(PD)バイオマーカー 市場規模の事業概要 地域別 2018 VS 2022 VS 2029
  • 世界の薬力学的(PD)バイオマーカー 市場規模:地域別 (2018-2029)
  • 世界の薬力学的(PD)バイオマーカーの市場規模実績:地域別 (2018-2023)
  • 世界の薬力学的(PD)バイオマーカー 市場規模予測:地域別 (2024-2029)
  • 主要地域別, 薬力学的(PD)バイオマーカー 市場規模 (2018-2029)
    • 北米の薬力学的(PD)バイオマーカー 市場規模 (2018-2029)
    • Europe Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)
    • Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)
    • Latin America Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)
    • Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)

第2章 薬力学的(PD)バイオマーカー 市場:タイプ別

  • 概要
    • 曝露バイオマーカー
    • エフェクトバイオマーカー
    • 感受性バイオマーカー
  • 世界の薬力学的(PD)バイオマーカー 市場規模:タイプ別: 2018 VS 2022 VS 2029
    • 世界の薬力学的(PD)バイオマーカーの市場規模実績:タイプ別 (2018-2023)
    • 世界の薬力学的(PD)バイオマーカーの市場規模予測:タイプ別 (2024-2029)
  • 主要地域別 市場規模:タイプ別
    • 北米の薬力学的(PD)バイオマーカー 収益 内訳 タイプ別 (2018-2029)
    • 欧州の薬力学的(PD)バイオマーカー 収益 内訳 タイプ別 (2018-2029)
    • アジア太平洋地域 薬力学的(PD)バイオマーカー 収益 内訳 タイプ別 (2018-2029)
    • ラテンアメリカの薬力学的(PD)バイオマーカー 収益 内訳 タイプ別 (2018-2029)
    • 中東・アフリカの薬力学的(PD)バイオマーカー 収益 内訳 タイプ別 (2018-2029)

第3章 薬力学的(PD)バイオマーカー 市場の事業概要 用途別

  • 概要
    • 診断
    • 創薬
    • 個別化医療
    • その他
  • 世界の薬力学的(PD)バイオマーカー 市場規模:用途別: 2018 VS 2022 VS 2029
    • 世界の薬力学的(PD)バイオマーカーの市場規模実績:用途別 (2018-2023)
    • 世界の薬力学的(PD)バイオマーカーの市場規模予測:用途別 (2024-2029)
  • 主要地域別 市場規模:用途別
    • 北米の薬力学的(PD)バイオマーカー 収益 内訳 用途別 (2018-2029)
    • 欧州の薬力学的(PD)バイオマーカー 収益 内訳 用途別 (2018-2029)
    • アジア太平洋地域 薬力学的(PD)バイオマーカー 収益 内訳 用途別 (2018-2029)
    • ラテンアメリカの薬力学的(PD)バイオマーカー 収益 内訳 用途別 (2018-2029)
    • 中東・アフリカの薬力学的(PD)バイオマーカー 収益 内訳 用途別 (2018-2029)

第4章 薬力学的(PD)バイオマーカー 競合分析:企業別

  • 世界の薬力学的(PD)バイオマーカー 市場規模:企業別 (2018-2023)
  • 世界のトップ企業:タイプ別(Tier1、Tier2、Tier3)& (売上高に基づいた in 薬力学的(PD)バイオマーカー (2022年時点))
  • 主要企業の参入時期 薬力学的(PD)バイオマーカー 市場
  • 世界のトッププレーヤー 薬力学的(PD)バイオマーカー 本社 および提供地域
  • 主要企業 薬力学的(PD)バイオマーカーの製品ソリューションおよびサービス
  • 競合の状況
    • 薬力学的(PD)バイオマーカーの市場:濃度別
    • M&A, 拡張計画

第5章 企業(トッププレーヤー)プロフィール

  • Thermo Fisher Scientific
  • Merck
  • Bio-Rad Laboratories
  • QIAGEN
  • Roche
  • Danaher Corporation
  • Siemens Healthcare
  • Abbott
  • Agilent Technologies

第6章 北米

  • 北米の薬力学的(PD)バイオマーカー 市場規模:国別 (2018-2029)
  • 米国
  • カナダ

第7章 欧州

  • 欧州の薬力学的(PD)バイオマーカー 市場規模:国別 (2018-2029)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア
  • 北欧
  • その他の欧州地域

第8章 アジア太平洋地域

  • アジア太平洋地域 薬力学的(PD)バイオマーカー 市場規模:地域別 (2018-2029)
  • 中国
  • 日本
  • 韓国
  • 東南アジア
  • インド
  • オーストラリア
  • その他のアジア太平洋地域

第9章 ラテンアメリカ

  • ラテンアメリカの薬力学的(PD)バイオマーカー 市場規模:国別 (2018-2029)
  • メキシコ
  • ブラジル
  • その他のラテンアメリカ地域

第10章 中東・アフリカ

  • 中東・アフリカの薬力学的(PD)バイオマーカー 市場規模:国別 (2018-2029)
  • トルコ
  • サウジアラビア
  • UAE
  • その他の中東・アフリカ地域

第11章 薬力学的(PD)バイオマーカー 市場動向

  • 薬力学的(PD)バイオマーカー 業界動向
  • 薬力学的(PD)バイオマーカー 市場の促進要因
  • 薬力学的(PD)バイオマーカー 市場の課題
  • 薬力学的(PD)バイオマーカー 市場の抑制要因

第12章 研究成果と結論

第13章 方法論とデータソース

  • 調査アプローチ
    • 研究プログラム/設計
    • 市場規模の予測
    • 市場細分化とデータの三角測量
  • データソース
    • 二次資料
    • 一次資料
  • 免責事項
  • 著者一覧
図表

List of Tables

  • Table 1. Global Market Pharmacodynamic (PD) Biomarkers Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
  • Table 2. Global Pharmacodynamic (PD) Biomarkers Market Size by Region (2018-2023) & (US$ Million)
  • Table 3. Global Pharmacodynamic (PD) Biomarkers Market Size Share by Region (2018-2023)
  • Table 4. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 5. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size Share by Region (2024-2029)
  • Table 6. Global Pharmacodynamic (PD) Biomarkers Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
  • Table 7. Global Pharmacodynamic (PD) Biomarkers Market Size by Type (2018-2023) & (US$ Million)
  • Table 8. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2018-2023)
  • Table 9. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 10. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2024-2029)
  • Table 11. North America Pharmacodynamic (PD) Biomarkers Revenue by Type (2018-2023) & (US$ Million)
  • Table 12. North America Pharmacodynamic (PD) Biomarkers Revenue by Type (2024-2029) & (US$ Million)
  • Table 13. Europe Pharmacodynamic (PD) Biomarkers Revenue by Type (2018-2023) & (US$ Million)
  • Table 14. Europe Pharmacodynamic (PD) Biomarkers Revenue by Type (2024-2029) & (US$ Million)
  • Table 15. Asia-Pacific Pharmacodynamic (PD) Biomarkers Revenue by Type (2018-2023) & (US$ Million)
  • Table 16. Asia-Pacific Pharmacodynamic (PD) Biomarkers Revenue by Type (2024-2029) & (US$ Million)
  • Table 17. Latin America Pharmacodynamic (PD) Biomarkers Revenue by Type (2018-2023) & (US$ Million)
  • Table 18. Latin America Pharmacodynamic (PD) Biomarkers Revenue by Type (2024-2029) & (US$ Million)
  • Table 19. Middle East and Africa Pharmacodynamic (PD) Biomarkers Revenue by Type (2018-2023) & (US$ Million)
  • Table 20. Middle East and Africa Pharmacodynamic (PD) Biomarkers Revenue by Type (2024-2029) & (US$ Million)
  • Table 21. Global Pharmacodynamic (PD) Biomarkers Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
  • Table 22. Global Pharmacodynamic (PD) Biomarkers Market Size by Application (2018-2023) & (US$ Million)
  • Table 23. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2018-2023)
  • Table 24. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 25. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2024-2029)
  • Table 26. North America Pharmacodynamic (PD) Biomarkers Revenue by Application (2018-2023) & (US$ Million)
  • Table 27. North America Pharmacodynamic (PD) Biomarkers Revenue by Application (2024-2029) & (US$ Million)
  • Table 28. Europe Pharmacodynamic (PD) Biomarkers Revenue by Application (2018-2023) & (US$ Million)
  • Table 29. Europe Pharmacodynamic (PD) Biomarkers Revenue by Application (2024-2029) & (US$ Million)
  • Table 30. Asia-Pacific Pharmacodynamic (PD) Biomarkers Revenue by Application (2018-2023) & (US$ Million)
  • Table 31. Asia-Pacific Pharmacodynamic (PD) Biomarkers Revenue by Application (2024-2029) & (US$ Million)
  • Table 32. Latin America Pharmacodynamic (PD) Biomarkers Revenue by Application (2018-2023) & (US$ Million)
  • Table 33. Latin America Pharmacodynamic (PD) Biomarkers Revenue by Application (2024-2029) & (US$ Million)
  • Table 34. Middle East and Africa Pharmacodynamic (PD) Biomarkers Revenue by Application (2018-2023) & (US$ Million)
  • Table 35. Middle East and Africa Pharmacodynamic (PD) Biomarkers Revenue by Application (2024-2029) & (US$ Million)
  • Table 36. Global Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) by Players (2018-2023)
  • Table 37. Global Pharmacodynamic (PD) Biomarkers Revenue Market Share by Players (2018-2023)
  • Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmacodynamic (PD) Biomarkers as of 2022)
  • Table 39. Date of Key Players Enter into Pharmacodynamic (PD) Biomarkers Market
  • Table 40. Global Pharmacodynamic (PD) Biomarkers Key Players Headquarters and Area Served
  • Table 41. Pharmacodynamic (PD) Biomarkers Product Solution and Service
  • Table 42. Global Pharmacodynamic (PD) Biomarkers Players Market Concentration Ratio (CR5 and HHI)
  • Table 43. Mergers & Acquisitions, Expansion Plans
  • Table 44. Thermo Fisher Scientific Basic Information List
  • Table 45. Thermo Fisher Scientific Description and Business Overview
  • Table 46. Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 47. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of Thermo Fisher Scientific (2018-2023)
  • Table 48. Thermo Fisher Scientific Recent Developments
  • Table 49. Merck Basic Information List
  • Table 50. Merck Description and Business Overview
  • Table 51. Merck Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 52. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of Merck (2018-2023)
  • Table 53. Merck Recent Developments
  • Table 54. Bio-Rad Laboratories Basic Information List
  • Table 55. Bio-Rad Laboratories Description and Business Overview
  • Table 56. Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 57. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of Bio-Rad Laboratories (2018-2023)
  • Table 58. Bio-Rad Laboratories Recent Developments
  • Table 59. QIAGEN Basic Information List
  • Table 60. QIAGEN Description and Business Overview
  • Table 61. QIAGEN Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 62. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of QIAGEN (2018-2023)
  • Table 63. QIAGEN Recent Developments
  • Table 64. Roche Basic Information List
  • Table 65. Roche Description and Business Overview
  • Table 66. Roche Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 67. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of Roche (2018-2023)
  • Table 68. Roche Recent Developments
  • Table 69. Danaher Corporation Basic Information List
  • Table 70. Danaher Corporation Description and Business Overview
  • Table 71. Danaher Corporation Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 72. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of Danaher Corporation (2018-2023)
  • Table 73. Danaher Corporation Recent Developments
  • Table 74. Siemens Healthcare Basic Information List
  • Table 75. Siemens Healthcare Description and Business Overview
  • Table 76. Siemens Healthcare Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 77. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of Siemens Healthcare (2018-2023)
  • Table 78. Siemens Healthcare Recent Developments
  • Table 79. Abbott Basic Information List
  • Table 80. Abbott Description and Business Overview
  • Table 81. Abbott Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 82. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of Abbott (2018-2023)
  • Table 83. Abbott Recent Developments
  • Table 84. Agilent Technologies Basic Information List
  • Table 85. Agilent Technologies Description and Business Overview
  • Table 86. Agilent Technologies Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
  • Table 87. Revenue (US$ Million) in Pharmacodynamic (PD) Biomarkers Business of Agilent Technologies (2018-2023)
  • Table 88. Agilent Technologies Recent Developments
  • Table 89. North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2018-2023) & (US$ Million)
  • Table 90. North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2024-2029) & (US$ Million)
  • Table 91. Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2018-2023) & (US$ Million)
  • Table 92. Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2024-2029) & (US$ Million)
  • Table 93. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 94. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2018-2023) & (US$ Million)
  • Table 95. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2024-2029) & (US$ Million)
  • Table 96. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Share by Region (2018-2023)
  • Table 97. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Share by Region (2024-2029)
  • Table 98. Latin America Pharmacodynamic (PD) Biomarkers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 99. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2018-2023) & (US$ Million)
  • Table 100. Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2024-2029) & (US$ Million)
  • Table 101. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 102. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2018-2023) & (US$ Million)
  • Table 103. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2024-2029) & (US$ Million)
  • Table 104. Pharmacodynamic (PD) Biomarkers Market Trends
  • Table 105. Pharmacodynamic (PD) Biomarkers Market Drivers
  • Table 106. Pharmacodynamic (PD) Biomarkers Market Challenges
  • Table 107. Pharmacodynamic (PD) Biomarkers Market Restraints
  • Table 108. Research Programs/Design for This Report
  • Table 109. Key Data Information from Secondary Sources
  • Table 110. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Pharmacodynamic (PD) Biomarkers Market Size Year-over-Year 2018-2029 & (US$ Million)
  • Figure 2. Global Pharmacodynamic (PD) Biomarkers Market Size (US$ Million), 2018 VS 2022 VS 2029
  • Figure 3. Global Pharmacodynamic (PD) Biomarkers Market Share by Regions: 2022 VS 2029
  • Figure 4. Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size Share by Region (2024-2029)
  • Figure 5. North America Pharmacodynamic (PD) Biomarkers Market Size Growth Rate (2018-2029) & (US$ Million)
  • Figure 6. Europe Pharmacodynamic (PD) Biomarkers Market Size Growth Rate (2018-2029) & (US$ Million)
  • Figure 7. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size Growth Rate (2018-2029) & (US$ Million)
  • Figure 8. Latin America Pharmacodynamic (PD) Biomarkers Market Size Growth Rate (2018-2029) & (US$ Million)
  • Figure 9. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size Growth Rate (2018-2029) & (US$ Million)
  • Figure 10. Product Picture of Exposure Biomarkers
  • Figure 11. Global Exposure Biomarkers Market Size (US$ Million) & YoY Growth (2018-2029)
  • Figure 12. Product Picture of Effect Biomarkers
  • Figure 13. Global Effect Biomarkers Market Size (US$ Million) & YoY Growth (2018-2029)
  • Figure 14. Product Picture of Susceptibility Biomarkers
  • Figure 15. Global Susceptibility Biomarkers Market Size (US$ Million) & YoY Growth (2018-2029)
  • Figure 16. Global Pharmacodynamic (PD) Biomarkers Market Size Share by Type: 2022 & 2029
  • Figure 17. North America Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2018-2029)
  • Figure 18. Europe Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2018-2029)
  • Figure 19. Asia-Pacific Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2018-2029)
  • Figure 20. Latin America Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2018-2029)
  • Figure 21. Middle East and Africa Pharmacodynamic (PD) Biomarkers Revenue Market Share by Type (2018-2029)
  • Figure 22. Diagnostics Market Size (US$ Million) & YoY Growth (2018-2029)
  • Figure 23. Drug Discovery Market Size (US$ Million) & YoY Growth (2018-2029)
  • Figure 24. Personalized Medicine Market Size (US$ Million) & YoY Growth (2018-2029)
  • Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2029)
  • Figure 26. Global Pharmacodynamic (PD) Biomarkers Market Size Share by Application: 2022 & 2029
  • Figure 27. North America Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2018-2029)
  • Figure 28. Europe Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2018-2029)
  • Figure 29. Asia-Pacific Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2018-2029)
  • Figure 30. Latin America Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2018-2029)
  • Figure 31. Middle East and Africa Pharmacodynamic (PD) Biomarkers Revenue Market Share by Application (2018-2029)
  • Figure 32. Pharmacodynamic (PD) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
  • Figure 33. Global Top 5 and Top 10 Players Pharmacodynamic (PD) Biomarkers Market Share in 2022
  • Figure 34. North America Pharmacodynamic (PD) Biomarkers Market Share by Country (2018-2029)
  • Figure 35. U.S. Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 36. Canada Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 37. Germany Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 38. France Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 39. U.K. Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 40. Italy Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 41. Russia Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 42. Nordic Countries Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 43. Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Share by Region (2018-2029)
  • Figure 44. China Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 45. Japan Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 46. South Korea Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 47. Southeast Asia Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 48. India Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 49. Australia Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 50. Latin America Pharmacodynamic (PD) Biomarkers Market Share by Country (2018-2029)
  • Figure 51. Mexico Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 52. Brazil Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 53. Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Share by Country (2018-2029)
  • Figure 54. Turkey Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 55. Saudi Arabia Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 56. UAE Pharmacodynamic (PD) Biomarkers Market Size (2018-2029) & (US$ Million)
  • Figure 57. Bottom-up and Top-down Approaches for This Report
目次

This research report focuses on the Pharmacodynamic (PD) Biomarkers Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Market Overview of Pharmacodynamic (PD) Biomarkers

  • 1.1 Pharmacodynamic (PD) Biomarkers Market Overview
    • 1.1.1 Pharmacodynamic (PD) Biomarkers Product Scope
    • 1.1.2 Pharmacodynamic (PD) Biomarkers Market Status and Outlook
  • 1.2 Global Pharmacodynamic (PD) Biomarkers Market Size Overview by Region 2018 VS 2022 VS 2029
  • 1.3 Global Pharmacodynamic (PD) Biomarkers Market Size by Region (2018-2029)
  • 1.4 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Region (2018-2023)
  • 1.5 Global Pharmacodynamic (PD) Biomarkers Market Size Forecast by Region (2024-2029)
  • 1.6 Key Regions, Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)
    • 1.6.1 North America Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)
    • 1.6.2 Europe Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)
    • 1.6.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)
    • 1.6.4 Latin America Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)
    • 1.6.5 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size (2018-2029)

2 Pharmacodynamic (PD) Biomarkers Market by Type

  • 2.1 Introduction
    • 2.1.1 Exposure Biomarkers
    • 2.1.2 Effect Biomarkers
    • 2.1.3 Susceptibility Biomarkers
  • 2.2 Global Pharmacodynamic (PD) Biomarkers Market Size by Type: 2018 VS 2022 VS 2029
    • 2.2.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Type (2018-2023)
    • 2.2.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Type (2024-2029)
  • 2.3 Key Regions Market Size by Type
    • 2.3.1 North America Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Type (2018-2029)
    • 2.3.2 Europe Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Type (2018-2029)
    • 2.3.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Type (2018-2029)
    • 2.3.4 Latin America Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Type (2018-2029)
    • 2.3.5 Middle East and Africa Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Type (2018-2029)

3 Pharmacodynamic (PD) Biomarkers Market Overview by Application

  • 3.1 Introduction
    • 3.1.1 Diagnostics
    • 3.1.2 Drug Discovery
    • 3.1.3 Personalized Medicine
    • 3.1.4 Others
  • 3.2 Global Pharmacodynamic (PD) Biomarkers Market Size by Application: 2018 VS 2022 VS 2029
    • 3.2.1 Global Pharmacodynamic (PD) Biomarkers Historic Market Size by Application (2018-2023)
    • 3.2.2 Global Pharmacodynamic (PD) Biomarkers Forecasted Market Size by Application (2024-2029)
  • 3.3 Key Regions Market Size by Application
    • 3.3.1 North America Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Application (2018-2029)
    • 3.3.2 Europe Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Application (2018-2029)
    • 3.3.3 Asia-Pacific Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Application (2018-2029)
    • 3.3.4 Latin America Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Application (2018-2029)
    • 3.3.5 Middle East and Africa Pharmacodynamic (PD) Biomarkers Revenue Breakdown by Application (2018-2029)

4 Pharmacodynamic (PD) Biomarkers Competition Analysis by Players

  • 4.1 Global Pharmacodynamic (PD) Biomarkers Market Size by Players (2018-2023)
  • 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pharmacodynamic (PD) Biomarkers as of 2022)
  • 4.3 Date of Key Players Enter into Pharmacodynamic (PD) Biomarkers Market
  • 4.4 Global Top Players Pharmacodynamic (PD) Biomarkers Headquarters and Area Served
  • 4.5 Key Players Pharmacodynamic (PD) Biomarkers Product Solution and Service
  • 4.6 Competitive Status
    • 4.6.1 Pharmacodynamic (PD) Biomarkers Market Concentration Rate
    • 4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

  • 5.1 Thermo Fisher Scientific
    • 5.1.1 Thermo Fisher Scientific Profile
    • 5.1.2 Thermo Fisher Scientific Main Business
    • 5.1.3 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.1.4 Thermo Fisher Scientific Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.1.5 Thermo Fisher Scientific Recent Developments
  • 5.2 Merck
    • 5.2.1 Merck Profile
    • 5.2.2 Merck Main Business
    • 5.2.3 Merck Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.2.4 Merck Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.2.5 Merck Recent Developments
  • 5.3 Bio-Rad Laboratories
    • 5.3.1 Bio-Rad Laboratories Profile
    • 5.3.2 Bio-Rad Laboratories Main Business
    • 5.3.3 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.3.4 Bio-Rad Laboratories Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.3.5 QIAGEN Recent Developments
  • 5.4 QIAGEN
    • 5.4.1 QIAGEN Profile
    • 5.4.2 QIAGEN Main Business
    • 5.4.3 QIAGEN Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.4.4 QIAGEN Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.4.5 QIAGEN Recent Developments
  • 5.5 Roche
    • 5.5.1 Roche Profile
    • 5.5.2 Roche Main Business
    • 5.5.3 Roche Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.5.4 Roche Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.5.5 Roche Recent Developments
  • 5.6 Danaher Corporation
    • 5.6.1 Danaher Corporation Profile
    • 5.6.2 Danaher Corporation Main Business
    • 5.6.3 Danaher Corporation Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.6.4 Danaher Corporation Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.6.5 Danaher Corporation Recent Developments
  • 5.7 Siemens Healthcare
    • 5.7.1 Siemens Healthcare Profile
    • 5.7.2 Siemens Healthcare Main Business
    • 5.7.3 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.7.4 Siemens Healthcare Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.7.5 Siemens Healthcare Recent Developments
  • 5.8 Abbott
    • 5.8.1 Abbott Profile
    • 5.8.2 Abbott Main Business
    • 5.8.3 Abbott Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.8.4 Abbott Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.8.5 Abbott Recent Developments
  • 5.9 Agilent Technologies
    • 5.9.1 Agilent Technologies Profile
    • 5.9.2 Agilent Technologies Main Business
    • 5.9.3 Agilent Technologies Pharmacodynamic (PD) Biomarkers Products, Services and Solutions
    • 5.9.4 Agilent Technologies Pharmacodynamic (PD) Biomarkers Revenue (US$ Million) & (2018-2023)
    • 5.9.5 Agilent Technologies Recent Developments

6 North America

  • 6.1 North America Pharmacodynamic (PD) Biomarkers Market Size by Country (2018-2029)
  • 6.2 U.S.
  • 6.3 Canada

7 Europe

  • 7.1 Europe Pharmacodynamic (PD) Biomarkers Market Size by Country (2018-2029)
  • 7.2 Germany
  • 7.3 France
  • 7.4 U.K.
  • 7.5 Italy
  • 7.6 Russia
  • 7.7 Nordic Countries
  • 7.8 Rest of Europe

8 Asia-Pacific

  • 8.1 Asia-Pacific Pharmacodynamic (PD) Biomarkers Market Size by Region (2018-2029)
  • 8.2 China
  • 8.3 Japan
  • 8.4 South Korea
  • 8.5 Southeast Asia
  • 8.6 India
  • 8.7 Australia
  • 8.8 Rest of Asia-Pacific

9 Latin America

  • 9.1 Latin America Pharmacodynamic (PD) Biomarkers Market Size by Country (2018-2029)
  • 9.2 Mexico
  • 9.3 Brazil
  • 9.4 Rest of Latin America

10 Middle East & Africa

  • 10.1 Middle East & Africa Pharmacodynamic (PD) Biomarkers Market Size by Country (2018-2029)
  • 10.2 Turkey
  • 10.3 Saudi Arabia
  • 10.4 UAE
  • 10.5 Rest of Middle East & Africa

11 Pharmacodynamic (PD) Biomarkers Market Dynamics

  • 11.1 Pharmacodynamic (PD) Biomarkers Industry Trends
  • 11.2 Pharmacodynamic (PD) Biomarkers Market Drivers
  • 11.3 Pharmacodynamic (PD) Biomarkers Market Challenges
  • 11.4 Pharmacodynamic (PD) Biomarkers Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

  • 13.1 Methodology/Research Approach
    • 13.1.1 Research Programs/Design
    • 13.1.2 Market Size Estimation
    • 13.1.3 Market Breakdown and Data Triangulation
  • 13.2 Data Source
    • 13.2.1 Secondary Sources
    • 13.2.2 Primary Sources
  • 13.3 Disclaimer
  • 13.4 Author List